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ABSTRACT 
 
Paediatric Chronic Fatigue Syndrome or Myalgic Encephalomyelitis (CFS/ME) affects at least 
1% of secondary school children in the UK and is very disabling. Treatment is effective but 
few children get a diagnosis or access treatment. This paper summarises what we currently 
know about diagnosing and treating this important illness in childhood.  
 
INTRODUCTION 
Paediatric Chronic Fatigue Syndrome or Myalgic Encephalomyelitis (CFS/ME)1 is relatively 
common, affecting between 0.1 and 2% of secondary school children2-5. It has significant 
impact on the lives of young people; school absence, periods of being bedbound and long-
term consequences for physical health, psychological wellbeing, social development and 
overall quality of life6-10.  Young people report a “feeling of being forgotten, invisible and left 
behind” 11 . Multiple qualitative studies have found that young people feel a sense of loss in 
several areas of life, including family, friendships and schooling11 12 13 and young people 
report experiencing disbelief and distrust from others14 . This may contribute to why young 
people with CFS/ME have significantly impaired quality of life, even when compared with 
children and adolescents with other chronic illnesses15. 
Having a child with CFS/ME affects the whole family16 and is costly for the NHS. Specialist 
treatment is effective and therefore making a diagnosis and ensuring children can access 
treatment is important. 
 
DIAGNOSIS AND REFERRAL 
 
Young people with CFS/ME have persistent and disabling fatigue. Many teenagers (up to 
34% in some studies) have significant fatigue17-19. The fatigue experienced by children with 
CFS/ME is qualitatively different and disabling with a significant impact on function.  Most 
(62%) of those attending specialist services attend only two days a week of school or less20 
and children give up social activities and hobbies13.  Post-exertional malaise is a core 
symptom and is an increase in fatigue and symptoms after doing more than usual. For most 
children, this means that they miss time off school at the end of the week.  In those who are 
severely affected they may have an increase in symptoms after a small amount of activity 
such as walking down stairs. Different diagnostic criteria require different numbers of 
symptoms. Table 1 describes the different diagnostic criteria used. In the UK clinicians use 
The National Institute for Health and Clinical Excellence (NICE) guidance1, however, most 
research studies use the Fukuda21 or Centers for Disease Control and Prevention (CDC) 
criteria22. The Canadian criteria23 and the Institute of Medicine (IOM) criteria24 are used in 
some studies. CFS/ME is a diagnosis of exclusion and other explanations for the fatigue must 
be ruled out via clinical assessment (including blood tests, see Table 2).  
 
Paediatric CFS/ME is heterogeneous with at least three different phenotypes25 described in 
table 3. This is consistent with adult data where 3-5 different phenotypes are described. 
This means that children will present with different clusters of symptoms and may explain 
why different children respond to different treatments.  
 
Diagnosis and referral is valued by families affected by CFS/ME; mothers reported finding 
specialist CFS/ME services useful in recognising and acknowledging their child's condition 
and opening channels of dialogue between health-care professionals and education 
providers. Adolescents report that specialist medical care results in better symptom 
management26. 
 
TREATMENT AND MANAGEMENT 
 
Children with CFS/ME have the right to access specialist treatment1.  Those with mild 
CFS/ME are typically mobile, able to care for themselves and the majority will by attending 
school, although they will often be taking days off. They will probably have stopped leisure 
and social pursuits, and will be using the weekend for rest. These young people with mild 
CFS/ME should be referred to specialist paediatric CFS/ME services within 6 months1. Young 
people with moderate CFS/ME have reduced mobility and are restricted in all activities of 
daily living, often having peaks and troughs of ability. They are likely to be missing periods of 
schooling. These individuals should be referred within 3-4months1.  Young people with 
severe CFS/ME should be referred immediately1. A young person is deemed to have severe 
CFS/ME if they are unable to do activities for themselves, can only carry out minimal daily 
tasks, or if they have severe cognitive difficulties and depend on wheelchair for mobility1. 
Few children access specialist services within these time frames27.  
 
NICE recommends that children with CFS/ME are offered either Cognitive Behavioural 
Therapy (CBT), Activity Management or Graded Exercise Therapy (GET). These approaches 
should also include advice on sleep and symptom management. Some young people present 
with complex presentations, so individualised management plans1 should be developed 
including treatment for co-morbidities such as mood disorders,  eating difficulties and 
obesity. Clinicians may also address more systemic issues such as how the CFS/ME affects 
family members28, and how families should be involved in treatment29.  
 
The largest evidence-base is for CBT-type interventions; five randomised controlled trials of 
CBT for CFS/ME in adolescents have shown that it is an effective treatment approach30-34.  
There is a limited evidence base for GET.  Although there are several trials in adults35 , there 
are no trials investigating GET in the outpatient setting. A randomised controlled is currently 
in progress comparing the effectiveness of GET to Activity Management in children aged 8-
1736.   
 
Activity Management and GET are behavioural approaches that work on changing the 
boom-bust pattern of activity (or exercise in GET) to a more stable “baseline” before 
increasing it.  For children and families with more complex needs (such as co-morbid mood 
disorders) and for those who find change too difficult, CBT may be the more appropriate 
treatment; it includes the behavioural elements, but also uses cognitive approaches to 
support psychological needs and encourage behaviour change.   
 
Activity Management 
Activity Management is delivered by multi-disciplinary health professionals (including 
occupational therapists, physiotherapists, nurses and psychologists). This behavioural 
intervention targets the “boom-bust” pattern of activity; fluctuations of over activity and 
underactivity, where young people engage in high levels of activity on “good” days with 
consequential “bad” days of low activity37,38, as shown in Figure 1. 
 
The clinician assesses the patient’s current levels of activity, recording detailed information 
about cognitive activities (school work, reading, socialising, and screen time (phone, laptop, 
TV, games)), emotional activities and physical activities. The clinician agrees a “baseline” of 
activity with the young person; a daily sustainable level of activity, which is typically the 
average amount of activity that the young person reports at assessment28.   
Young people are taught how to record the total number of minutes spent each day doing 
different levels of activity (high-energy and low-energy).  Recording activity is used to help 
participants understand whether they are doing the same each day or varying their activity 
and whether the baseline has been set at the correct level. Young people are able to use 
either paper diaries or digital Apps to record and monitor activity.    
 
When participants have achieved their baseline, they are supported to increase this. NICE 
guidance recommends a gradual increase1. Studies have used different approaches, most 
studies increase activity by 10-20% each week36 with a gradual return to school if this is the 
child’s goal, and to normal social activity39. Activity Management should be structured, 
tailored to the child’s goals, active, and an incremental approach to rehabilitation1,40.  
Therapists discuss problems encountered by participants and provide possible solutions. 
Setbacks are discussed and manged, by appropriately adapting behavioural plans.  
 
 
Graded Exercise Therapy 
Graded Exercise Therapy (GET) uses a similar approach but focuses only on exercise. This 
means that there needs to be an appropriate physical assessment, with goal-setting and a 
rehabilitation plan created based on physical goals1. It should be prescribed by a suitably 
qualified/trained therapist and should be offered to young people with mild or moderate 
CFS/ME1. GET probably works in several ways. For some, GET stops children and young 
people doing too much exercise on good days and helps to establish a consistent amount of 
physical activity every day. For other children, it helps them to gain stamina and increase 
their cardiovascular tolerance to exercising. 
 
The young person’s physical activity is assessed and a baseline is set by the clinician. The 
total amount of physical activity the young person does i.e. walking around school, playing 
and participating in active hobbies are all taken into consideration when devising the 
tailored treatment plan of a physical activity baseline level and a GET training programme. A 
musculoskeletal assessment may also be conducted to check for muscle tightness, weakness 
or joint hypermobility. Short and long term goals are set. The GET programme starts at a 
low intensity.  Walking is the easiest exercise to access as it is functional and cheap. The 
walk duration is initially set by the therapist following an assessment of the young person’s 
current ability. The walk should be carried out at their own steady pace with a heart rate 
between 40-50% of their Maximum heart rate, and be continuous. This should be carried 
out at least five times a week. Once this has been achieved and maintained, without a daily 
fluctuation in overall activity levels, the young person can increase the duration of the walk 
to reach 30 minutes. This is done carefully with a graduated approach, increasing 10-25% 
every 3-14 days. Once the young person is able to carry out 30 minutes of low intensity 
exercise 5-7 days a week, they can begin to increase the intensity of the walk, using interval 
training. The training heart rate will aim to rise between 50-70%1 of their maximum heart 
rate. Using a heart rate monitor can avoid over exercising which can lead to an exacerbation 
in symptoms.  The Graded Exercise Model is displayed in Figure 2.  
 
It is important to warn the young person and their parents that there can be a slight 
increase in symptoms when physical activity levels are increased which is normal. Frequent 
assessments are used to check that the young person is not over doing it. Children are 
warned that a reduction in function may mean the baseline needs to be reassessed.   
The use of technology (activity monitors/pedometers/heart rate monitors) can help the 
young person to understand the principles of GET and aid them to monitor and adjust their 
individual programme.   
 
Cognitive Behavioural Therapy 
The cognitive behavioural model of CFS/ME Suggests that although fatigue is triggered by 
(for example) an infection, it is maintained by: behavioural responses to fatigue such as 
over-exertion or excessive rest; and emotional factors such as depression, frustration and 
anxiety41. In some cases, children (and parents) are understandably anxious about 
reproducing symptoms and this makes engagement with rehabilitation much harder.  
 
CBT aims to counter the cognitive and behavioural factors that maintain fatigue. When a 
child experiences chronic fatigue, they change what they do (e.g. by reducing activity levels), 
driven by thoughts such as ‘I need to rest to recover’. A graded approach to stabilising and 
then increasing activity (physical and mental), and sleep management strategies are used to 
tackle the behavioural cycles1. Identifying and challenging unhelpful cognitions, and 
developing more helpful cognitions is done with the behavioural programme1. Cognitive 
processes are tackled by shifting attention away from the symptom of fatigue using 
attentional retraining principles42. Children and families are reminded that it is normal to 
feel tired at times, just not consistently so and not to the extent of significantly limiting 
functioning. Therefore, the aim of treatment is not for an individual never to be tired again; 
instead, the aim is for the child to be capable of doing everything that they want to do, 
which typically includes a return to full time education30 . Parents are commonly involved in 
treatment sessions.  
 
Engaging in CBT requires a degree of concentration and attention, and its success is 
premised on an individual doing work in between sessions to notice patterns and make 
changes in their daily lives, at both a cognitive and behavioural level. Therefore, for some 
children, even if the CBT is adapted by the therapist to accommodate for their symptoms of 
fatigue, the demands of the therapy may be too much.    
 
More recently studies have looked beyond face-face delivery, exploring telephone33 and 
online delivery of CBT31. Despite NICE guideline that young people should be referred to 
specialist CFS/ME services, most young people in the UK are unable to access such services 
locally. Many children experience significant barriers to accessing care with delayed access 
and prolonged periods of ill health before treatment27. Once solution may be to provide 
online CBT; which has been shown to be effective in the Netherlands31. A large Randomised 
controlled trial, “FITNET-NHS”, is currently in progress to investigate the clinical 
effectiveness and cost-effectives of internet delivered CBT in UK NHS services.  
 
Managing Sleep 
Young people with CFS/ME characteristically present with sleep difficulties, unusual sleep 
patterns (such as day-night reversal) and unrefreshing sleep 2,43. Clinicians should take a 
good sleep history, identify the individual’s problems and then work with the family to 
improve sleep quality. The most important strategies are to reduce excessive sleeping as 
this will improve sleep architecture. Clinicians should agree the maximum number of hours 
the young person will sleep and then set a wake-up time. The going to sleep time can be 
calculated by subtracting the maximum time from this.  
Adrenal function is disturbed in adolescents with CFS/ME with low salivary cortisol in the 
morning28. This gets better with treatment44. Setting a regular wake up time for weekends 
as well as weekdays is important to restore normal diurnal cortisol patterns  
Melatonin can also be used to help young people get off to sleep if they still take more than 
20 minutes to get off to sleep after sleep restriction and a regular waking up time.  
Suggested regimens include starting with 2mg doses 30 minutes before sleep is desired, if 
the child is in bed and ready for sleep. The dose can be increased incrementally but if it is 
ineffective at 6mg, it is not likely to work at higher doses.  It does not usually help to 
maintain sleep through the night, even if the slow release preparation is used. No 
preparations are licensed for use in children, but Circadin®(slow release) has recently been 
added to the British National Formulary for Children (BNFC, UK guidance on prescribing and 
pharmacology) for shared care prescribing. It should be noted that there is a limited 
evidence base for melatonin45. 
 
 
Managing Pain  
Pain is a common symptom; around 20% of patients have a pain phenotype, where 
musculoskeletal pain is the predominant symptoms alongside fatigue46. Adult patients who 
experience pain have a less favourable outcome, and this may also be true for younger 
patients. 
If chronic pain is a predominant feature, clinicians should consider referral to a specialist 
pain management clinic. Psychological treatments for pain are principally, but not 
exclusively, cognitive and behavioural treatments. These treatments encourage active 
engagement and self-management by the young person with behavioural strategies to 
support normal daily activities, an increased awareness of the role of cognition in suffering, 
a focus on the self-regulation of emotion, and the use of techniques for reducing aversive 
arousal (e.g., relaxation)47. In terms of medical management of pain, simple analgesics such 
as ibuprofen are first line treatments.  Amitriptyline may be used an initial 10mg dose 
gradually increased up to 1mg/kg (maximum 50 mg daily). Amitriptyline side effects can 
include drowsiness, so it can also be useful given in the evening, for those who have 
difficulty getting off to sleep. It may take up to three weeks for the effects to be seen. 
Opiates should not be prescribed to children and adolescents with CFS/ME and pain.  
 
 
 
MANAGING COMORBID CONDITIONS 
 
Managing Mood 
Depression and anxiety are more common in children with CFS/ME than in the general 
population, and are associated with markers of disease severity9. In qualitative studies the 
majority (but not all) of the young people interviewed, described their CFS/ME as preceding 
either their depression13 or the anxiety14. However the direction of causality is not known9. 
Whilst the treatment approaches for CFS/ME may help children with either depression or 
anxiety, it is not clear which treatment approaches should be used in those with co-morbid 
mood disorders48,49.For some children their negative thinking, hopelessness and 
helplessness or anxiety is so severe that it may impede treatment for CFS/ME. In these 
children, it may be helpful to refer children for specialist assessment and treatment for their 
mood.  . NICE recommends treating any comorbid mood disorders as per standard clinical 
management, including selective serotonin reuptake inhibitor (SSRI) medications and talking 
therapies.  
 
Managing Eating difficulties 
An estimated 10% of young people with CFS/ME who access specialist services experience 
eating difficulties, which can have a significant impact on their quality of life, illness and on 
their families50. Not eating increases fatigue, low mood and anxiety which further 
exacerbates the eating difficulties. Clinicians should screen for eating difficulties in those 
with symptoms of nausea and abdominal pain, warn adolescents and their families of the 
risk of developing eating difficulties and provide interventions and support as early as 
possible50. NICE recommends offering advices such as eating little and often, snacking on 
dry starchy foods and sipping fluids. The use of antiemetic drugs should be considered only 
if nausea is severe1. Exclusion diets are not generally recommended by NICE, and dieticians 
should be consulted in this instance due to risk of malnutrition. Individuals may find 
exclusion diets helpful in managing symptoms, including bowel symptoms1. 
 
Managing Weight 
Young people with CFS/ME are at increased risk of obesity51. This may be due to decreased 
levels of physical activity and/or increased time spent doing sedentary activities, although 
the temporal relationship between CFS/ME and weight has not been established. Obesity is 
associated with a range of diseases, and clinicians should consider screening and offering 
advice for managing weight as per NICE guidance when they see patients with CFS/ME.  For 
most children, this is likely to involve dietary changes as increasing exercise to manage 
weight is not always possible.  
 
DO CHILDREN GET BETTER? 
Reported outcomes vary, but the prognosis in children and young people is more optimistic 
that in adults1. Four small studies (N=15–31) from the 1990s report that between 50%–94% 
of children make a good or complete recovery at 13–72 months52.  The largest trial to date 
demonstrated that most children with CFS/ME will recover within six to 12 months if they 
receive internet delivered CBT as treatment31. For those who don’t receive specialist care, 
recovery is much slower with  less than 10% recovering at six months31.  
 
 
FUTURE DIRECTIONS  
We need to develop better treatments for children with CFS/ME because even with the best 
treatments available, approximately 35% will still be ill after 6 months31. We also need to 
develop new approaches for those with mood disorders and younger children because 
outcomes for children in these groups are worse. Most children in the UK are still unable to 
access treatment and therefore we need to investigate different ways to deliver treatment 
(e.g. Video conferencing or Internet delivered CBT).   
 
 
USEFUL FURTHER READING 
 
Action for ME’s webpage on children and young people 
https://www.actionforme.org.uk/children-and-young-people/introduction 
 
Burgess M, Chalder T. Overcoming Chronic Fatigue: A self-help guide using cognitive 
behavioural techniques. London: Robinson; 2009. 
 
NICE guidance 
NICE. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis 
and management of CFS/ME in adults and children (NICE guidelines CG53). London 2007 
2007. CG53. 
 
Report to the Chief Medical Officer of an Independent Working Group 
http://www.erythos.com/gibsonenquiry/docs/cmoreport.pdf 
 
 
  
Table 1. Comparison of CFS/ME diagnostic criteria 
 
 CDC Criteria 
 
Canadian Criteria  NICE guidance 
Principal 
Symptom 
Fatigue Fatigue Fatigue 
Other symptoms At least 4 of: sore 
throat, tender lymph 
nodes, muscle pain, 
joint pain, headaches, 
unrefreshing sleep, 
post-exertional malaise, 
impaired memory or 
concentration.  
Post-exertional malaise 
and/or post-exertional 
fatigue, unrefreshing 
sleep or sleep 
disturbance, pain. 
Cognitive dysfunction.  
Malaise, headaches, sleep 
disturbances, difficulties with 
concentration and muscle 
pain and/or joint pain, painful 
lymph nodes, sore throat, 
dizziness and/or nausea, and 
palpitations with no 
identifiable heart problem. 
Onset Of new or definite 
onset (not lifelong) 
Not stated.  New, persistent and/or 
recurrent.  
Duration ≥ 6 months. Persistent 
or relapsing.  
≥ 3 months in a child or 
young person. Persistent 
or reoccurring.  
≥ 3 months in a child or 
young person.  
Impact on 
functioning 
Results in a substantial 
reduction in 
occupational, 
educational, social or 
personal functioning. 
Results in substantial 
reduction in previous 
levels of educational, 
social and personal 
functioning.  
Substantial reduction in 
activity levels. 
Exclusions Fatigue is not 
substantially alleviated 
by rest, and is not the 
result of ongoing 
exertion. Fatigue is 
clinically evaluated and 
unexplained.  
Fatigue is clinically 
evaluated and 
unexplained. 
Current psychiatric 
conditions that may 
explain the presence of 
chronic fatigue, including 
schizophrenia or 
psychotic disorders, 
bipolar disorder, alcohol 
or substance abuse, 
anorexia nervosa or 
bulimia nervosa and 
depressive disorders. 
Fatigue not explained by 
other conditions. The 
diagnosis of CFS/ME should 
be reconsidered if none of 
the following key 
features are present: 
post-exertional fatigue or 
malaise, 
cognitive difficulties, 
sleep disturbance, and 
chronic pain. 
Adapted from Loades et al (2016)48 
 
 
Table 2. Screening tests recommended by NICE 
 Full blood count 
 Creatinine, Urea and electrolytes 
 Thyroid function 
 Erythrocyte sedimentation rate/plasma viscosity 
 C-reactive protein 
 Random blood glucose 
 Screening blood tests for gluten sensitivity 
 Serum Calcium 
 Creatine Kinase 
 Ferritin levels 
 Urinalysis 
 
 
 
Table 3. Three different phenotypes of CFS/ME in children 
 
Phenotype 
  
      Description and key points  
 
Musculoskeletal  
 
 Characterised by muscle and joint pain  
 Stronger association with fatigue compared with other 
phenotypes  
Migraine  
 
 Characterised by headaches, abdominal pain, nausea and 
dizziness as well as noise, light and touch hypersensitivity 
 Strongest association with lower physical function and 
worse pain compared with other phenotypes 
 Associated with lower school attendance 
 Some evidence of association with anxiety 
 
Sore throat  
 
 Characterised by sore throat and tender lymph nodes  
 Appeared to be the least severely affected group with no 
association with fatigue and pain and less strong association 
with physical function 
 Associated with female gender 
Summarised from May et al. (2010) 
 
 
 
 Figure 2. Graded Exercise Model  
 
 
Figure 1. The boom-bust pattern of activity and the aims of activity management 
 
The green line represents the boom and bust pattern of activity. Activity management is 
represented in purple; young people are supported to initially establish a “baseline” of 
activity, and once they have managed this they are advised to gradually increase activity 
by 10-15% per week.  
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